Satellos Bioscience Inc Com V.ICO

Immune Spin out of lesser assets

[trumpmaster]

Immune is spinning out some other assets to focus on the main assets as described below, ICO is the patent holder..GO GO GO...ICO Trump Immune Pharmaceuticals The transaction will allow Immune to become a pure play immuno-inflammation, clinical stage. development company with all resources being allocated to its lead assets, bertilimumab and nano-cyclosporin, with a special interest in Immuno-Dermatology. Immunes core assets are bertilimumab, a first-in-class human monoclonal antibody targeted at eotaxin-1, currently in phase 2 development in bullous pemphigoid and ulcerative colitis, with a planned phase 2 in severe atopic dermatitis, and a proprietary topical nano-cyclosporine for the treatment of atopic dermatitis and of moderate psoriasis. Read more at https://www.stockhouse.com/news/press-releases/2017/07/19/immune-pharmaceuticals-provides-update-on-plan-to-implement-a-spin-off-of#csEdtQk84dDmVjVR.99